Sumanta K. Pal, Medical Oncologist at City of Hope, posted the following on X:
“Terrific AUC3 debate between Michiel van der Heijden and Roger Li on NMIBC management (local v systemic). As both concede, data for emerging local therapies very compelling, but possibly (possibly) a role for local + systemic.
Great paper from Roger in Nature Medicine that supports this approach.”
Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial
Authors: Roger Li et al.
